| GEN |
Report |
Operating revenue |
IN-LINE |
pred ~$1.320B vs. cons $1.314B |
MEDIUM |
| GEN |
Report |
Operating diluted EPS |
IN-LINE |
pred ~$0.695 vs. cons $0.690 |
MEDIUM |
| GEN |
Report |
MoneyLion operating revenue |
IN-LINE |
pred ~$270.0M vs. cons $268.8M |
MEDIUM |
| GEN |
Guide |
FY27 revenue |
UNCHANGED |
guide midpoint ~$5.375B vs. cons $5.378B |
MEDIUM |
| GEN |
Guide |
FY27 non-GAAP EPS |
UNCHANGED |
guide midpoint ~$2.90 vs. cons $2.893 |
MEDIUM |
| GEN |
Guide |
FY27 Q2 revenue |
UNCHANGED |
guide midpoint ~$1.324B vs. cons $1.324B |
LOW |
| GEN |
Guide |
FY27 Q2 non-GAAP EPS |
UNCHANGED |
guide midpoint ~$0.710 vs. cons $0.710 |
LOW |
| GEN |
Return |
Day-1 residual (stock − beta × S&P 500) |
-1.5% |
— |
LOW |
| GEN |
Return |
5-day cumulative residual |
-2.5% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — unchanged forward estimates meet a high stock bar |
LOW |